Miracle Mile Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Miracle Mile Advisors's IBB Position: Q3 2026 in Review
Miracle Mile Advisors reduced its iShares Biotechnology ETF (IBB) stake by 0.28% in Q3 2026, selling an estimated $6.22K and leaving 11,135 shares worth $2.34M. The position accounts for 0.03% of the portfolio, ranked #306.
Miracle Mile Advisors first reported a position in IBB in Q1 2019 and has held it in 21 quarters since. The position peaked at $41.1M in Q2 2023. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Miracle Mile Advisors held 11,135 shares of iShares Biotechnology ETF worth $2.34M as of Q3 2026.
- Miracle Mile Advisors sold 31 iShares Biotechnology ETF shares in Q3 2026, an estimated $6.22K.
- iShares Biotechnology ETF made up 0.03% of Miracle Mile Advisors's portfolio in Q3 2026, its #306 holding.
- Miracle Mile Advisors first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 21 quarters since.
- Miracle Mile Advisors's iShares Biotechnology ETF position peaked at $41.1M in Q2 2023.
- 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Miracle Mile Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.